首页> 美国卫生研究院文献>Diabetes >A Novel Mechanism by Which SDF-1β Protects Cardiac Cells From Palmitate-Induced Endoplasmic Reticulum Stress and Apoptosis via CXCR7 and AMPK/p38 MAPK-Mediated Interleukin-6 Generation
【2h】

A Novel Mechanism by Which SDF-1β Protects Cardiac Cells From Palmitate-Induced Endoplasmic Reticulum Stress and Apoptosis via CXCR7 and AMPK/p38 MAPK-Mediated Interleukin-6 Generation

机译:SDF-1β通过CXCR7和AMPK / p38 MAPK介导的白介素6生成保护心肌细胞免受棕榈酸酯诱导的内质网应激和凋亡的新机制。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

We studied the protective effect of stromal cell-derived factor-1β (SDF-1β) on cardiac cells from lipotoxicity in vitro and diabetes in vivo. Exposure of cardiac cells to palmitate increased apoptosis by activating NADPH oxidase (NOX)–associated nitrosative stress and endoplasmic reticulum (ER) stress, which was abolished by pretreatment with SDF-1β via upregulation of AMP-activated protein kinase (AMPK)–mediated p38 mitogen-activated protein kinase (MAPK) phosphorylation and interleukin-6 (IL-6) production. The SDF-1β cardiac protection could be abolished by inhibition of AMPK, p38 MAPK, or IL-6. Activation of AMPK or addition of recombinant IL-6 recaptured a similar cardiac protection. SDF-1β receptor C-X-C chemokine receptor type 4 (CXCR4) antagonist AMD3100 or CXCR4 small interfering RNA could not, but CXCR7 small interfering RNA completely abolished SDF-1β’s protection from palmitate-induced apoptosis and activation of AMPK and p38 MAPK. Administration of SDF-1β to diabetic rats, induced by feeding a high-fat diet, followed by a small dose of streptozotocin, could significantly reduce cardiac apoptosis and increase AMPK phosphorylation along with prevention of diabetes-induced cardiac oxidative damage, inflammation, hypertrophy, and remodeling. These results showed that SDF-1β protects against palmitate-induced cardiac apoptosis, which is mediated by NOX-activated nitrosative damage and ER stress, via CXCR7, to activate AMPK/p38 MAPK–mediated IL-6 generation. The cardiac protection by SDF-1β from diabetes-induced oxidative damage, cell death, and remodeling was also associated with AMPK activation.
机译:我们研究了基质细胞衍生因子-1β(SDF-1β)对体外脂毒性和体内糖尿病的心脏细胞的保护作用。通过激活NADPH氧化酶(NOX)相关的亚硝化应激和内质网(ER)应激,使心肌细胞暴露于棕榈酸酯可增加细胞凋亡,而SDF-1β预处理可通过上调AMP激活的蛋白激酶(AMPK)介导的p38来消除这种应激有丝分裂原激活的蛋白激酶(MAPK)磷酸化和白介素6(IL-6)的产生。通过抑制AMPK,p38 MAPK或IL-6可以取消SDF-1β的心脏保护作用。 AMPK的激活或重组IL-6的添加重新获得了类似的心脏保护作用。 SDF-1β受体4型C-X-C趋化因子受体拮抗剂AMD3100或CXCR4小干扰RNA不能,但是CXCR7小干扰RNA完全废除了SDF-1β对棕榈酸酯诱导的凋亡以及AMPK和p38 MAPK活化的保护。喂高脂饮食诱导糖尿病大鼠服用SDF-1β,然后再少量服用链脲佐菌素,可显着减少心脏凋亡并增加AMPK磷酸化,同时预防糖尿病引起的心脏氧化损伤,炎症,肥大,和重塑。这些结果表明,SDF-1β可以防止棕榈酸酯诱导的心脏凋亡,这种凋亡由NOX激活的亚硝化损伤和ER应激(通过CXCR7介导)来激活AMPK / p38 MAPK介导的IL-6生成。 SDF-1β对糖尿病引起的氧化损伤,细胞死亡和重塑的心脏保护作用也与AMPK激活有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号